UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 997

Sortiert nach

Organic Chemistry of Explosives

1. Aufl., 2007

Link zum Volltext

Verfügbarkeit prüfen

The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal

Health technology assessment (Winchester, England), 2017-02, Vol.21 (7), p.1-204

2017

Link zum Volltext

Verfügbarkeit prüfen

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

Science translational medicine, 2016-11, Vol.8 (363), p.363ra150

2016

Link zum Volltext

Verfügbarkeit prüfen

Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview

Journal of clinical epidemiology, 2017-10, Vol.90, p.108-118

2017

Link zum Volltext

Verfügbarkeit prüfen

Intensive behavioural interventions based on applied behaviour analysis (ABA) for young children with autism: A cost-effectiveness analysis

PloS one, 2022-08, Vol.17 (8), p.e0270833-e0270833

2022

Link zum Volltext

Verfügbarkeit prüfen

Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis

Health technology assessment (Winchester, England), 2020-07, Vol.24 (35), p.1-306

2020

Link zum Volltext

Verfügbarkeit prüfen

Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis

Health technology assessment (Winchester, England), 2023-12, Vol.27 (29), p.1-172

2023

Link zum Volltext

Verfügbarkeit prüfen

Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation

Health technology assessment (Winchester, England), 2020-09, Vol.24 (48), p.1-264

2020

Link zum Volltext

Verfügbarkeit prüfen

Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework

Health technology assessment (Winchester, England), 2021-12, Vol.25 (76), p.1-228

2021

Link zum Volltext

Verfügbarkeit prüfen

An Examination of Judge Reliability at a major U.S. Wine Competition

Journal of wine economics, 2008, Vol.3 (2), p.105-113

Hodgson, Robert T.

2008

Link zum Volltext

Verfügbarkeit prüfen

Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

Experimental neurology, 2010-10, Vol.225 (2), p.384-390

2010

Link zum Volltext

Verfügbarkeit prüfen

Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders

Experimental neurology, 2010-10, Vol.225 (2), p.384

2010

Link zum Volltext

Verfügbarkeit prüfen

The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)

The Journal of pharmacology and experimental therapeutics, 2008-08, Vol.326 (2), p.672

2008

Link zum Volltext

Verfügbarkeit prüfen

Methods for selecting the best evidence to inform a NICE technology appraisal on selective internal radiation therapies for hepatocellular carcinoma

Systematic reviews, 2020-08, Vol.9 (1), p.184-8, Article 184

2020

Link zum Volltext

Verfügbarkeit prüfen

Updated Creutzfeldt–Jakob disease infection control guidelines: sifting facts from fiction

Medical journal of Australia, 2013-10, Vol.199 (8), p.535-536

Hodgson, Robert A

2013

Link zum Volltext

Verfügbarkeit prüfen

The dual orexin receptor antagonist, DORA‐22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine

Journal of neurochemistry, 2017-07, Vol.142 (2), p.204-214

2017

Link zum Volltext

Verfügbarkeit prüfen

An Analysis of the Concordance Among 13 U.S. Wine Competitions

Journal of wine economics, 2009, Vol.4 (1), p.1-9

Hodgson, Robert T.

2009

Link zum Volltext

Verfügbarkeit prüfen

Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: Sensitivity to anxiolytic and antidepressant drugs

Pharmacology, biochemistry and behavior, 2008, Vol.88 (3), p.341-348

2008

Link zum Volltext

Verfügbarkeit prüfen

“It's driving her mad”: Gender differences in the effects of commuting on psychological health

Journal of health economics, 2011-09, Vol.30 (5), p.1064-1076

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior

European journal of pharmacology, 2014-05, Vol.730, p.157-163

2014

Link zum Volltext

Verfügbarkeit prüfen

Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model

Pharmacology, biochemistry and behavior, 2014-03, Vol.118, p.36-45

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

European journal of pharmacology, 2014-04, Vol.728, p.31-38

2014

Link zum Volltext

Verfügbarkeit prüfen

The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates

Psychopharmacologia, 2008-10, Vol.200 (3), p.393-401

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 997

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(848)
Mit Volltextzugriff
(907)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Organic Chemistry of Explosives

The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients

Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview

Intensive behavioural interventions based on applied behaviour analysis (ABA) for young children with autism: A cost-effectiveness analysis

Discovery of the 3‑Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β‑Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease

Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis

Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis

Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation

Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework

An Examination of Judge Reliability at a major U.S. Wine Competition

Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders

The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles

The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)

Methods for selecting the best evidence to inform a NICE technology appraisal on selective internal radiation therapies for hepatocellular carcinoma

Updated Creutzfeldt–Jakob disease infection control guidelines: sifting facts from fiction

The dual orexin receptor antagonist, DORA‐22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine

An Analysis of the Concordance Among 13 U.S. Wine Competitions

Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: Sensitivity to anxiolytic and antidepressant drugs

“It's driving her mad”: Gender differences in the effects of commuting on psychological health

Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior

Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates

Suchergebnisse filtern